miR-100 inhibits cell proliferation in mantle cell lymphoma by targeting mTOR
- PDF / 5,163,016 Bytes
- 17 Pages / 595.276 x 790.866 pts Page_size
- 61 Downloads / 176 Views
Experimental Hematology & Oncology Open Access
RESEARCH
miR‑100 inhibits cell proliferation in mantle cell lymphoma by targeting mTOR Luhui Lin1, Yiqun Huang1, Wei Zhuang1, Ping Lin2 and Xudong Ma1*
Abstract Background: miR-100 is reported to be associated with cell proliferation and apoptosis. However, the function of miR-100 in mantle cell lymphoma (MCL) is unknown. The purpose of this study is to analyze the abnormal expression of miR-100 and mTOR in MCL together with their potential biological function and pathogenesis. Method: Eighteen MCL tissue samples and 3 cell lines (Jeko-1, Mino, Granta-519) were investigated in this research study, while eighteen samples of proliferative lymphadenitis from patients and peripheral lymphocyte cells from healthy volunteers served as controls. The expression and alteration of miR-100 and mTOR mRNA were detected by RT-PCR. The expression and alteration of mTOR protein were explored by Western blot. LV-miR-100-up and LV-mTORRNAi were constructed and transfected by lentivirus transfection. Cell proliferation, cell apoptosis and the cell cycle were detected using CCK-8 and flow cytometry. Bioinformatics prediction software was used to predict the miR-100 target gene of mTOR. A double luciferase experiment was used to verify miR-100 targeting at the mTOR-3′-UTR. The interaction between miR-100 and mTOR was further studied using recovery experiments. GraphPad Prism 7 software (version 7.2) was used for statistical analysis, and a P value 58
10
4
6
13
6
7
5
3
2
Present
2
0
2
Absent
16
9
7
Data Loading...
